What are you looking for? Search Common searches: Intranet, Contact, Map, Professionals, Teaching units, Research groups, Fulltext search Tipus de contingut Professionals Projects Teaching Units Collaborating entities News Activities - Any - Search News A phase I clinical trial with Vall d'Hebron participation shows good results of a drug against childhood cancer Dr. Lucas Moreno and Dr. Constantino Sábado, researchers of the Translational Research Group in Childhood and Adolescent Cancer, are two of the leaders of the international study. News A Vall d’Hebron study relates the impact of obesity to cognitive impairment The mechanisms in obesity that cause mild cognitive impairment are similar to those of type 2 diabetes. Fat is a powerful cerebral toxin and risk factor: it causes delayed reaction times in both executive function and attention. News Vall d’Hebron participates in RESPONSE, a global phase III clinical trial for the treatment of primary biliary cholangitis The innovative oral drug could provide a new therapeutic option for people with PBC who have not obtained the recommended therapeutic outcome or who do not tolerate first line therapy and cannot continue their treatment. News Recruitment of volunteers starts for the Phase III clinical trial of the HIPRA COVID-19 vaccine The trial, which already has AEMPS authorisation, will be conducted in Spain, Portugal and Italy. News Celebrem la II Jornada d’Actualització en Infeccions de Transmissió Sexual en el context de la infecció pel VIH L'objectiu de la jornada és revisar les Infeccions de Transmissió Sexual (ITS) amb major impacte clínic i de salut pública amb un enfocament teòric-pràctic a través de casos clínics interactius que facilitin la discussió i l’aprenentatge. News The story ‘We love you, little brave!’ donates its benefits to the Pediatric Cardiology Service of Vall d'Hebron Anna Gutiérrez's son was born in November 2019 with a congenital heart disease, for which he was operated on when he was five days old. Experience that inspired her to write the story ‘We love you, little brave!’. News Vall d’Hebron enrolls the first patient in a Phase IIb clinical trial by Oryzon for Borderline Personality Disorder The PORTICO study will evaluate the efficacy and safety of vafidemstat in Borderline Personality Disorder patients. Pioneers Pioneers is a project that aims to humanize Vall d’Hebron through art and give visibility to the gifts that have marked a before and after in the health sciences. News Precision medicine and innovation in research, protagonists at the World Cancer Day Conference The Vall d’Hebron Barcelona Hospital Campus has organised the World Cancer Day Conference as part of World Cancer Day, today, 4 February. News A project led by Laia Ventura, a Vall d'Hebron nurse, wins an award from the General Council of Nursing The work "Family presence during invasive procedures in pediatrics: perceptions, attitudes and practices of nurses" has received the Research Award of the General Council of Nursing in the category of Young Promises in Nursing Research. Pagination Previous page ‹‹ Page 110 Next page ››